08.01.25 -- STREAM Edition: Building An Efficient Biopharma

Reflecting on his experience at other drug companies, Dr. Srinivas Rao emphasizes the importance of prioritizing patient-reported outcomes and starting with the end in mind. atai designed its VLS-01 compound to fit existing healthcare infrastructure and gained significant insight from the Spravato® path to market.

Watch and discover how to effectively utilize chromatography tools for improved purification of therapeutic monoclonal antibodies and antibody derivatives.

On this week's Business of Biotech, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean drug development company to address an unmet need observed in his own patients as a surgeon: safe treatments for acute pain.

Johnson & Johnson Senior Director Irina Ramos, Ph.D. joins Bioprocessing expert David Bruehlmann for this segment of the Bioprocess Online Live event Process Optimization or Full-Scale Automation. The two discuss differences in product quality between fed batch and continuous, handling disruptions and quality control strategies, environmental and regulatory impacts, and more.

Lumen Bioscience is putting the farm in biopharma — literally! In this episode of Better Biopharma, Lumen's EVP of production and development, Craig Behnke, Ph.D., explains the company's chlorophyll-powered approach to bioprocessing using photosynthetic cyanobacteria.

Explore advancements in emerging analytical technologies like Process Analytical Technology (PAT) and mass spectrometry, improving drug development through enhanced bioprocess monitoring and control.

In this presentation, experts provide insight into transposase-mediated genome engineering, genetic quality control, and the maintenance of genetic stability in cell line generation.